2040.80
-2.14%
CD Equisearch
Despite overall consolidated sales volume witnessing a decline of 13.8% to 27,589 mt in Q3FY22, Balaji Amines' revenue from operations grew by a pleasing 44.1% to Rs. 564.90 crs as against Rs. 392.13 crs in the corresponding period in the prior year. The demand for certain products from pharmaceutical clients remained suppressed on account of...
Balaji Amines has gained 90.70% in the last 6 Months
More from Balaji Amines Ltd.
Recommended